Pfizer Inc

NYSE: PFE
$25.96
+$0.31 (+1.2%)
Real Time Data Delayed 15 Min.

PFE Articles

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
The nearly eight-year old bull market endures, with markets recently hitting all-time highs. And how are short sellers reacting?
Johnson & Johnson, Pfizer, UnitedHealth, and Verizon lifted the DJIA on Thursday.
2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were Netflix and Facebook, and new entrants on the list included Uber and...
Pfizer, Cisco, JPMorgan, and Procter & Gamble lead the DJIA to another record high on Wednesday.
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.
24/7 Wall St. has put together a preview of some of the major companies reporting on Tuesday, including Apple and two other Dow stocks.
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even further beyond 20,000.
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
Even though the new year is barely three weeks old, it's not too soon to take a look at how the 30 blue chip stocks included in the Dow Jones Industrial Average are faring.
Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
JPMorgan, Goldman Sachs, Pfizer, and UnitedHealth sink DJIA on Tuesday.
Disney, Microsoft, Pfizer, and Intel lead DJIA to lower close on Thursday.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...